Join ADLM
ADLM professional members save up to $550 on ADLM 2026. Join for just $275 a year and enjoy year-round benefits.
Explore ADLM 2026 through Scientific Pathways that connect sessions across topics, helping you discover content that matches your interests and build a personalized meeting experience.
These six pathways are cross-cutting and dynamic, complementing core topics while highlighting areas of high impact and market relevance in clinical laboratory medicine. They are designed to guide you through leading-edge science, emerging trends, and innovations shaping the field.
You can search pathway sessions for dates and times and all ADLM 2026 sessions using the online session.
Artificial intelligence, advanced analytics, and digital technologies are transforming every aspect of laboratory medicine—from workflow optimization and decision support to data-driven patient care. Explore this pathway to learn how laboratories are harnessing data, automation, and emerging technologies to improve quality, efficiency, and clinical impact. Explore data science (excludes Roundtables)
32445 Navigating reimbursement and coding: The basics, AI, and emerging healthcare technologies
Mon., July 27 | 12:30 PM – 2:00 PM | Rm 207CD
32446 Petri dishes and pixels: Applying digital imaging solutions to contemporary clinical microbiology practice
Mon., July 27 | 12:30 PM – 2:00 PM | Rm 208
32225 Life after AI deployment: A conversation on effective real-world performance monitoring
Mon., July 27 | 2:30 PM – 4:00 PM | Rm 207CD
32226 First, do no harm: Ethics at the crossroads of scientific integrity, AI, and DTC testing
Mon., July 27 | 2:30 PM – 4:00 PM | Rm 208
33102 Academy distinguished abstracts: Precision oncology diagnostics: AI, blood-based biomarkers, and longitudinal monitoring
Tue., July 28 | 10:30 AM – 12:00 PM | Rm 205
33108 ADLM Healthcare Forum: Future regulation and reimbursement for software and AI in the clinical laboratory
Tue., July 28 | 10:30 AM – 12:00 PM | Rm 210AB
33228 Academy guidance document on data analytics: Advancing data analytics maturity in the clinical laboratory for a data-driven future
Tue., July 28 | 2:30 PM – 4:00 PM | Rm 210AB
34106 The integration journey: Preparing clinical laboratorians for EHR/LIS implementation
Wed., July 29 | 10:30 AM – 12:00 PM | Rm 209
35102 Advancing equity in maternal drug testing: From ethical challenges to informatics solutions
Thu., July 30 | 10:30 AM – 12:00 PM | Rm 205
42105/52205 Reimagining the clinical laboratory: AI applications for today and the future
Mon., July 27 | 7:30 AM – 8:30 AM and 12:30 PM – 1:30 PM
42106/52206 AI-driven precision medicine: Integrating wearable data streams to stratify cardio-metabolic risk and management
Mon., July 27 | 7:30 AM – 8:30 AM and 12:30 PM – 1:30 PM
43104/53204 Data literacy in the clinical lab: What do I need to know?
Tue., July 28 | 7:30 AM – 8:30 AM and 12:30 PM – 1:30 PM
43106/53206 The future of middleware solutions: Benefits, considerations, and the emergence of AI
Tue., July 28 | 7:30 AM – 8:30 AM and 12:30 PM – 1:30 PM
43107/53207 Complex data analysis for dummies: Using ChatGPT prompts to enhance data analysis through coding
Tue., July 28 | 7:30 AM – 8:30 AM and 12:30 PM – 1:30 PM
43125/53225 Understanding machine learning algorithms: Key considerations, it’s not magic, it’s math
Tue., July 28 | 7:30 AM – 8:30 AM and 12:30 PM – 1:30 PM
43131/53231 Automate, analyze, act: Leveraging Excel for lab data efficiency
Tue., July 28 | 7:30 AM – 8:30 AM and 12:30 PM – 1:30 PM
44114/54214 Artificial intelligence driven supply chain management in clinical laboratories
Wed., July 29 | 7:30 AM – 8:30 AM and 12:30 PM – 1:30 PM
Novel biomarkers are reshaping how diseases are detected, monitored, and managed, enabling earlier intervention and more precise clinical decisions. Follow this pathway to discover the latest advances in biomarker science, from neurodegenerative disease and cardiovascular health to cancer and beyond. Explore novel biomarkers (excludes Roundtables)
32101 Biomarkers of traumatic brain injury: New guidance from the National Institute of Neurological Disorders and Stroke
Mon., July 27 | 10:30 AM – 12:00 PM | Rm 203
32103 Moving beyond creatinine to evaluate kidney function through novel biomarker panels
Mon., July 27 | 10:30 AM – 12:00 PM | Rm 206
32447 Clocking biological time: Measuring, standardizing, and influencing biological age
Mon., July 27 | 12:30 PM – 2:00 PM | Rm 209
32221 Enhancing CVD care: Leveraging new AHA/ACC guidelines, treatments, risk assessments, and innovative functional assays
Mon., July 27 | 2:30 PM – 4:00 PM | Rm 203
32223 Biomarkers for acute kidney injury: From physiology to practice with new clinical guidance
Mon., July 27 | 2:30 PM – 4:00 PM | Rm 206
33102 Academy distinguished abstracts: Precision oncology diagnostics: AI, blood-based biomarkers, and longitudinal monitoring
Tue., July 28 | 10:30 AM – 12:00 PM | Rm 205
33105 Transforming Alzheimer’s care: Implications of new clinical guidance
Tue., July 28 | 10:30 AM – 12:00 PM | Rm 207CD
33222 The sFlt-1:PlGF ratio in the evaluation of preeclampsia
Tue., July 28 | 2:30 PM – 4:00 PM | Rm 205
34222 Lipoprotein(a) could be the next public health revolution: Are clinical laboratories ready for the challenge?
Wed., July 29 | 2:30 PM – 4:00 PM | Rm 205
34227 Current and future landscape of tumor markers in clinical use: Applications, challenges, and perspectives
Wed., July 29 | 2:30 PM – 4:00 PM | Rm 210AB
35101 Beyond blood: The frontier of noninvasive fluid diagnostics
Thu., July 30 | 10:30 AM – 12:00 PM | Rm 203
35103 Update on thyroid function tests and efforts to improve their reliability
Thu., July 30 | 10:30 AM – 12:00 PM | Rm 206
42109/52209 Navigating clinical implementation challenges for traumatic brain injury (TBI) biomarker assays
Mon., July 27 | 7:30 AM – 8:30 AM and 12:30 PM – 1:30 PM
42113/52213 Neurofilament light chain testing from start to finish: Challenges and implementation strategies for multiple sclerosis management
Mon., July 27 | 7:30 AM – 8:30 AM and 12:30 PM – 1:30 PM
42125/52225 Exerkines: From molecular messengers of exercise to clinical biomarkers of health and resilience
Mon., July 27 | 7:30 AM – 8:30 AM and 12:30 PM – 1:30 PM
42127/52227 Are we there yet? Clinical implementation of multi-cancer early detection (MCED) tests for preventive oncology
Mon., July 27 | 7:30 AM – 8:30 AM and 12:30 PM – 1:30 PM
43108/53208 Alzheimer’s disease biomarkers: Assay selection, performance considerations, and result interpretation
Tue., July 28 | 7:30 AM – 8:30 AM and 12:30 PM – 1:30 PM
43111/53211 Status of testosterone and estradiol testing in light of new guidelines and recommendations
Tue., July 28 | 7:30 AM – 8:30 AM and 12:30 PM – 1:30 PM
43128/53228 Impact of sFlt-1 and PlGF testing on the management of women with suspected preeclampsia in a high-risk obstetrics unit
Tue., July 28 | 7:30 AM – 8:30 AM and 12:30 PM – 1:30 PM
44111/54211 Emerging blood-based biomarkers in neurodegenerative disease diagnosis and management
Wed., July 29 | 7:30 AM – 8:30 AM and 12:30 PM – 1:30 PM
191308 Regulatory round-up: Hands-on workshop for navigating common laboratory deficiencies in point-of-care testing (POCT)
Sun., July 26 | 9:00 AM – 4:00 PM | Room
12001 Laboratory diagnostics for space medicine
Mon., July 27 | 8:45 AM – 10:00 AM | Rm Ballroom ABC
42110/52210 Alternative matrix samples: Challenges in body fluid testing and assay validation
Mon., July 27 | 7:30 AM – 8:30 AM and 12:30 PM – 1:30 PM
42131/52231 Advanced care at home experience at Mayo Clinic and role of lab medicine
Mon., July 27 | 7:30 AM – 8:30 AM and 12:30 PM – 1:30 PM
43101/53201 Point of care on the fast track: Managing growth, complexity, and compliance for large POCT programs
Tue., July 28 | 7:30 AM – 8:30 AM and 12:30 PM – 1:30 PM
43103/53203 Raising the bar in point-of-care waived testing beyond regulatory minimums
Tue., July 28 | 7:30 AM – 8:30 AM and 12:30 PM – 1:30 PM
43114/53214 Unifying POCT lab critical result notification documentation with analytics insight
Tue., July 28 | 7:30 AM – 8:30 AM and 12:30 PM – 1:30 PM
44101/54201 Empowering point-of-care excellence: Optimizing provider-performed microscopy (PPM) testing
Wed., July 29 | 7:30 AM – 8:30 AM and 12:30 PM – 1:30 PM
44102/54202 POCT in the autopsy suite: Screening for ketoacidosis as a cause of death
Wed., July 29 | 7:30 AM – 8:30 AM and 12:30 PM – 1:30 PM
44106/54206 ADLM remote sampling task force: Review and management topics
Wed., July 29 | 7:30 AM – 8:30 AM and 12:30 PM – 1:30 PM
44128/54228 What a pair: Implementing point of care viscoelastic testing in pediatric care
Wed., July 29 | 7:30 AM – 8:30 AM and 12:30 PM – 1:30 PM
32104 Wearable devices for diagnostics, is this point-of-care testing?
Mon., July 27 | 10:30 AM – 12:00 PM | Rm 207AB
32222 Newborn screening across Europe and the USA, what can we learn from each other?
Mon., July 27 | 2:30 PM – 4:00 PM | Rm 205
32224 POCT across the continuum: From real-time results to measurable impact
Mon., July 27 | 2:30 PM – 4:00 PM | Rm 207AB
33226 Addressing scientific gaps in POCT
Tue., July 28 | 2:30 PM – 4:00 PM | Rm 208
34221 Patient centric sampling for clinical diagnostics: Overcoming barriers to routine adoption
Wed., July 29 | 2:30 PM – 4:00 PM | Rm 203
34228 Alternative sampling for rapid toxicology screening by mass spectrometry
Wed., July 29 | 2:30 PM – 4:00 PM | Rm 210CD
35101 Beyond blood: The frontier of noninvasive fluid diagnostics
Thu., July 30 | 10:30 AM – 12:00 PM | Rm 203
32103 Moving beyond creatinine to evaluate kidney function through novel biomarker panels
Mon., July 27 | 10:30 AM – 12:00 PM | Rm 206
32108 Beyond clinical care: Ethical, legal, and social implications of third-party uses of DNA
Mon., July 27 | 10:30 AM – 12:00 PM | Rm 210AB
32447 Clocking biological time: Measuring, standardizing, and influencing biological age
Mon., July 27 | 2:30 PM – 4:00 PM | Rm 203
32221 Enhancing CVD care: Leveraging new AHA/ACC guidelines, treatments, risk assessments, and innovative functional assays
Mon., July 27 | 12:30 PM – 2:00 PM | Rm 209
33101 Clinical Chemistry Journal hot topics: New approaches to personalized reference ranges
Tue., July 28 | 10:30 AM – 12:00 PM | Rm 203
33105 Transforming Alzheimer’s care: Implications of new clinical guidance
Tue., July 28 | 10:30 AM – 12:00 PM | Rm 207CD
33222 The sFlt-1:PlGF ratio in the evaluation of preeclampsia
Tue., July 28 | 2:30 PM – 4:00 PM | Rm 205
34102 Hypertensive disorders of pregnancy: Cardiovascular implications
Wed., July 29 | 10:30 AM – 12:00 PM | Rm 205
34107 Critical review and update of clinical guidelines for immune-mediated conditions: ANA reporting, antiphospholipid syndrome and multiple sclerosis
Wed., July 29 | 10:30 AM – 12:00 PM | Rm 210AB
34222 Lipoprotein(a) could be the next public health revolution: Are clinical laboratories ready for the challenge?
Wed., July 29 | 2:30 PM – 4:00 PM | Rm 205
34227 Current and future landscape of tumor markers in clinical use: Applications, challenges, and perspectives
Wed., July 29 | 2:30 PM – 4:00 PM | Rm 210AB
35102 Advancing equity in maternal drug testing: From ethical challenges to informatics solutions
Thu., July 30 | 10:30 AM – 12:00 PM | Rm 205
42106/52206 AI-driven precision medicine: Integrating wearable data streams to stratify cardio-metabolic risk and management
Mon., July 27 | 7:30 AM – 8:30 AM and 12:30 PM – 1:30 PM
42113/52213 Neurofilament light chain testing from start to finish: Challenges and implementation strategies for multiple sclerosis management
Mon., July 27 | 7:30 AM – 8:30 AM and 12:30 PM – 1:30 PM
42124/52224 Serology tests for celiac disease diagnosis and follow up in children
Mon., July 27 | 7:30 AM – 8:30 AM and 12:30 PM – 1:30 PM
42127/52227 Are we there yet? Clinical implementation of multi-cancer early detection (MCED) tests for preventive oncology
Mon., July 27 | 7:30 AM – 8:30 AM and 12:30 PM – 1:30 PM
43108/53208 Alzheimer’s disease biomarkers: Assay selection, performance considerations, and result interpretation
Tue., July 28 | 7:30 AM – 8:30 AM and 12:30 PM – 1:30 PM
43122/53222 Beyond LDL-C: Case-based algorithms for complex lipid and lipoprotein profiles
Tue., July 28 | 7:30 AM – 8:30 AM and 12:30 PM – 1:30 PM
43128/53228 Impact of sFlt-1 and PlGF testing on the management of women with suspected preeclampsia in a high-risk obstetrics unit
Tue., July 28 | 7:30 AM – 8:30 AM and 12:30 PM – 1:30 PM
43130/53230 Therapeutic drug monitoring for hydroxychloroquine; teaching an old drug new tricks?
Tue., July 28 | 7:30 AM – 8:30 AM and 12:30 PM – 1:30 PM
44111/54211 Emerging blood-based biomarkers in neurodegenerative disease diagnosis and management
Wed., July 29 | 7:30 AM – 8:30 AM and 12:30 PM – 1:30 PM
44124/54224 Interpreting high-sensitive cardiac troponin results: Sex-specific or uniform upper reference limits?
Wed., July 29 | 7:30 AM – 8:30 AM and 12:30 PM – 1:30 PM
44130/54230 Phosphatidylethanol (Peth) and post-liver transplant complications
Wed., July 29 | 7:30 AM – 8:30 AM and 12:30 PM – 1:30 PM
14001 Advances in screening for cervical cancer both in the United States and globally
Wed., July 29 | 8:45 AM – 10:00 AM | Rm Ballroom ABC
32106 Tick-borne diseases: Beyond Lyme disease
Mon., July 27 | 10:30 AM – 12:00 PM | Rm 208
32108 Beyond clinical care: Ethical, legal, and social implications of third-party uses of DNA
Mon., July 27 | 10:30 AM – 12:00 PM | Rm 210AB
32222 Newborn screening across Europe and the USA, what can we learn from each other?
Mon., July 27 | 2:30 PM – 4:00 PM | Rm 205
32226 First, do no harm: Ethics at the crossroads of scientific integrity, AI, and DTC testing
Mon., July 27 | 2:30 PM – 4:00 PM | Rm 208
32227 Measuring what matters: A practical framework for advancing equitable healthcare, diversity, equity, and inclusion in laboratory medicine
Mon., July 27 | 2:30 PM – 4:00 PM | Rm 209
33109 Recreational use of nitrous oxide: Clinical cases and laboratory detection
Tue., July 28 | 10:30 AM – 12:00 PM | Rm 210CD
33229 Clinical laboratory realities for effective overdose biosurveillance
Tue., July 28 | 2:30 PM – 4:00 PM | Rm 210CD
34102 Hypertensive disorders of pregnancy: Cardiovascular implications
Wed., July 29 | 10:30 AM – 12:00 PM | Rm 205
34105 The shot not taken: Dangers of declining vaccination rates and impacts to the lab
Wed., July 29 | 10:30 AM – 12:00 PM | Rm 208
34222 Lipoprotein(a) could be the next public health revolution: Are clinical laboratories ready for the challenge?
Wed., July 29 | 2:30 PM – 4:00 PM | Rm 205
42111/52211 Emerging environmental toxins: PFAS forever chemicals and beyond
Mon., July 27 | 7:30 AM – 8:30 AM and 12:30 PM – 1:30 PM
42122/52222 Blood culture contamination rates: Collaboration for sustainable improvements
Mon., July 27 | 7:30 AM – 8:30 AM and 12:30 PM – 1:30 PM
42127/52227 Are we there yet? Clinical implementation of multi-cancer early detection (MCED) tests for preventive oncology
Mon., July 27 | 7:30 AM – 8:30 AM and 12:30 PM – 1:30 PM
43112/53212 Ferritin cutoffs and iron deficiency: Harmonizing manufacturer reference intervals with recent guidelines to prevent missed diagnosis
Tue., July 28 | 7:30 AM – 8:30 AM and 12:30 PM – 1:30 PM
43123/53223 HIV diagnostics: 40 years later!
Tue., July 28 | 7:30 AM – 8:30 AM and 12:30 PM – 1:30 PM
44115/54215 Exploring the solutions to hospitalization-associated iatrogenic anemia
Wed., July 29 | 7:30 AM – 8:30 AM and 12:30 PM – 1:30 PM
44118/54218From volume to value: Improving the outpatient lab requisition through evidence-based test selection
Wed., July 29 | 7:30 AM – 8:30 AM and 12:30 PM – 1:30 PM
44129/54229 Which specimen is best? Optimizing clinical toxicology workflows for the detection of in utero drug exposure
Wed, July 29 | 7:30 AM – 8:30 AM and 12:30 PM – 1:30 PM
Advances in microbiology are accelerating the detection, characterization, and management of infectious diseases. Follow this pathway to explore emerging technologies, molecular approaches, antimicrobial resistance strategies, and other innovations that are shaping the future of infectious disease diagnostics. Explore clinical microbiology (excludes Roundtables)
14001 Advances in screening for cervical cancer both in the United States and globally
Wed., July 29 | 8:45 AM – 10:00 AM | Rm Ballroom ABC
32106 Tick-borne diseases: Beyond Lyme disease
Mon., July 27 | 10:30 AM – 12:00 PM | Rm 208
32446 Petri dishes and pixels: Applying digital imaging solutions to contemporary clinical microbiology practice
Mon., July 27 | 12:30 PM – 2:00 PM | Rm 208
33106 Behind the bench: Navigating safety and science in prion disease testing
Tue., July 28 | 10:30 AM – 12:00 PM | Rm 208
33225 Parasitology in the clinical lab, it’s not just for micro anymore
Tue., July 28 | 2:30 PM – 4:00 PM | Rm 207CD
34105 The shot not taken: Dangers of declining vaccination rates and impacts to the lab
Wed., July 29 | 10:30 AM – 12:00 PM | Rm 208
34225 Confronting antimicrobial susceptibility testing challenges: Tools from CLSI
Wed., July 29 | 2:30 PM – 4:00 PM | Rm 208
42102 Sepsis diagnostics today and tomorrow: From procalcitonin and lactate to new FDA-cleared assays and AI-driven portable MS
Mon., July 27 | 7:30 AM – 8:30 AM and 12:30 PM – 1:30 PM
42122 Blood culture contamination rates: Collaboration for sustainable improvements
Mon., July 27 | 7:30 AM – 8:30 AM and 12:30 PM – 1:30 PM
43123 HIV diagnostics: 40 years later!
Tue., July 28 | 7:30 AM – 8:30 AM and 12:30 PM – 1:30 PM
44122 Fungal taxonomy updates, Candida auris, and antifungal resistance testing in clinical laboratories
Wed., July 29 | 7:30 AM – 8:30 AM and 12:30 PM – 1:30 PM